Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 271 papers

Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt

Jansen C, Schröder A, Schueler R, Lehmann J, Praktiknjo M, Uschner FE, Schierwagen R, Thomas D, Monteiro S, Nickenig G, Strassburg CP, Meyer C, Arroyo V, Hammerstingl C, Trebicka J.

Hepatol Commun 2019, 3(3): 340–347

DOI: 10.1002/hep4.1308

Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome

Lopategi A, Flores-Costa R, Rius B, López-Vicario C, Alcaraz-Quiles J, Titos E, Clària J.

J Leukoc Biol 2019, 105(1): 25–36

DOI: 10.1002/JLB.3HI0517-206RR

Management of acute liver failure – Clinical guideline from the Catalan Society of Digestology

Escorsell À, Castellote J, Sánchez-Delgado J, Charco R, Crespo G, Fernández J.

Gastroenterol Hepatol 2019, 42(1): 51–64

DOI: 10.1016/j.gastrohep.2018.07.013

Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study

Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC; International Variceal Bleeding Observational Study Group and Baveno Cooperation

Hepatology 2019, 69(1): 282–293

DOI: 10.1002/hep.30182

Statins: Old drugs as new therapy for liver diseases?

Pose E, Trebicka J, Mookerjee RP, Angeli P, Ginès P.

J Hepatol 2019, 70(1): 194–202

DOI: 10.1016/j.jhep.2018.07.019

Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis

Gustot T, Moreau R.

J Hepatol 2018, 69(6): 1384–1393

DOI: 10.1016/j.jhep.2018.08.024

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: Study protocol for a randomized controlled trial

Madsen BS, Trebicka J, Thiele M, Israelsen M, Arumugan M, Havelund T, Krag A.

Trials 2018, 19(1): 143

DOI: 10.1186/s13063-018-2523-9

Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis: Beyond the international normalized ratio

Blasi A, Calvo A, Prado V, Reverter E, Reverter JC, Hernández-Tejero M, Aziz F, Amoros A, Cardenas A, Fernández J.

Hepatology 2018, 68(6): 2325–2337

DOI: 10.1002/hep.30103

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation – A randomized placebo-controlled trial

Solà E, Solé C, Simón-Talero M, Martín-Llahí M, Castellote J, Garcia-Martínez R, Moreira R, Torrens M, Márquez F, Fabrellas N, de Prada G, Huelin P, Lopez Benaiges E, Ventura M, Manríquez M, Nazar A, Ariza X, Suñé P, Graupera I, Pose E, Colmenero J, Pavesi M, Guevara M, Navasa M, Xiol X, Córdoba J, Vargas V, Ginès P.

J Hepatol 2018, 69(6): 1250–1259

DOI: 10.1016/j.jhep.2018.08.006

Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis

Welz M, Eickhoff S, Abdullah Z, Trebicka J, Gartlan KH, Spicer JA, Demetris AJ, Akhlaghi H, Anton M, Manske K, Zehn D, Nieswandt B, Kurts C, Trapani JA, Knolle P, Wohlleber D, Kastenmüller W.

Nat Commun 2018, 9(1): 4805

DOI: 10.1038/s41467-018-07213-x